Dr. Dominic Walsh joined Biogen in September 2018 as head of the Alzheimer’s Disease & Dementia Research Unit and in March 2020 became head of the newly founded Neurodegenerative Diseases Research Unit (NDRU). Until recently he also served as the interim head of the Neuromuscular Research Unit. Dominic is responsible for overseeing Biogen’s research on Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease. He has worked on the molecular pathology of neurodegeneration since December 1991; has authored over 150 research articles, written several widely cited reviews and given over 100 invited lectures and webinars. He has served as an Editor or Editorial Advisor for several journals and as an ad hoc reviewer for all the world’s leading biomedical journals. Dominic has also served as a consultant and/or SAB member for several pharmaceutical and biotechnology companies. Prior to joining Biogen his research was supported by multiple agencies, grants from industry and donations from the public. He was named one of The World’s Most Influential Scientific Minds by Thomson Reuters and ranked among the top 1% of researchers in the field of Neuroscience and Behavior 2014 - 2016. Currently, Dominic is a SAB member of the Dementia Discovery Fund and of the UK Dementia Research Institute at Imperial College London. He is also an Honorary Professor at the Institute of Neurology, University College London.